Lesson 1: Patient Safety in Critical Care Medication Administration
  • Identifies standards from regulatory bodies
  • Culture of safety
  • Expanded the rights of medication administration
  • Includes new Joint Commission National Performance Goals 2026
  • Updated ISMP recommendations for look-alike sound-alike medications
  • Emphasis on the crucial role of clinical pharmacist partners in critical patient care
Lesson 2: Introduction to Pharmacology Principles I: Pharmacokinetics
  • New APRN consideration added on hormone therapy for transgender individuals
  • Revised Consult the Pharmacist answers the question “What happens when a tablet or capsule is inappropriately altered?”
  • Revised Safety Alert on transdermal medication to include FDA warnings on scopolamine patches
  • Expanded information on intramuscular and subcutaneous injections
Lesson 3: Introduction to Pharmacology Principles II: Pharmacodynamics
  • Pharmacodynamics
  • Medication Actions
  • Updated glossary definitions of peak and trough drug concentration levels, volume of distribution, steady state, and receptor
Lesson 4: Vasoactive Medications
  • Expanded information on the safe peripheral administration of vasoactive medications and on the treatment of extravasation
  • Updated information on the use of vasodilators in patients with traumatic brain injury
  • Updated and clarified sepsis content based on current guidelines on Hour-1 Bundle elements
  • Practice Pointer on the impact of skin tone on pulse oximetry added
Lesson 5: Antiarrhythmic Medications
  • Cardiac Conduction
  • Cardiac Hypoxia and Dysrhythmia Development
  • Antidysrhythmic Medications
  • Atrial Fibrillation
  • Information on management of atrial fibrillation, including cardioversion, ablation, and anticoagulation, updated based on the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation
  • Revised resource document “Antiarrhythmic Medications by Classification”
Lesson 6: Neuromuscular Blocking Agents
  • The minimized usage of neuromuscular blocking agents is emphasized except in narrow patient populations due to complications of neuromuscular blockade
  • Eye care recommendations updated
  • Added new content on prone positioning
Lesson 7: Medications for Pain and Sedation
  • Clarified the difference between self-reported pain and behavioral assessments
  • Added information on the importance of naloxone prescriptions for patients at high risk of opioid overdose
  • Clarified concepts of opioid tolerance, dependence, and withdrawal
  • Updated usage recommendations for dexmedetomidine and propofol
  • Expanded information on non-medical use of prescription medicines
  • Warning about ketamine dependence and misuse added
Lesson 8: Blood and Blood Products
  • Updated statistics on the use of blood and blood products in the United States
  • Myth vs. Fact updated to reflect current recommendations for the use of whole blood in patients with trauma
  • Recommendations for platelets updated
  • Safety Alert on tranexamic acid updated
  • Updated guidance on permissive hypotension, crystalloids and fluid resuscitation, colloids, trauma resuscitation strategies, transfusion thresholds, and safe transfusion practices